Access To Widely Scattered Data A Major Challenge For Evolving Health Care Industry: EY Report
There is a tremendous opportunity to use available data to improve health care, EY concludes, but life sciences companies must contend with siloed information and access issues, as well as shifts in who holds the most valuable data.
You may also be interested in...
From drug delivery by drone to busting the drug rebate model, panelists at CNBC's inaugural health care conference had big visions for the changes Amazon could bring to health care.
Biopharmas and other life sciences firms risk getting left behind by technology firms if they don't begin addressing patient needs more directly through data-driven technological advances, such as those to aid clinical development or treatment decisions with real-time patient data.
The merger of UnitedHealth Group’s pharmacy benefit manager OptumRx with Catamaran could give the combined firm greater pricing leverage as it becomes one of the industry's giants, along with CVS Health’s Caremark and Express Scripts.